Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.39 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26231357 | 0.99 | PLA2G2A (0.41) | HSD17B1HSD17B2PLA2G2APLA2G4AALDH1A1 | |
| SCHEMBL26231402 | 0.99 | PLA2G2A (0.41) | HSD17B1HSD17B2PLA2G2APLA2G4AALDH1A1 | |
| SCHEMBL27252327 | 0.97 | ALDH1A1 (0.43) | HSD17B1HSD17B2PLA2G2APLA2G4AALDH1A1 | |
| SCHEMBL26260471 | 0.97 | PLA2G2A (0.40) | HSD17B1HSD17B2PLA2G2APLA2G4AALDH1A1 | |
| SCHEMBL26231359 | 0.97 | PLA2G2A (0.40) | HSD17B1HSD17B2PLA2G2APLA2G4AALDH1A1 | |
| SCHEMBL23822680 | 0.97 | PLA2G2A (0.40) | HSD17B1HSD17B2PLA2G2APLA2G4AALDH1A1 | |
| SCHEMBL25817826 | 0.97 | ALDH1A1 (0.43) | HSD17B1HSD17B2PLA2G2APLA2G4AALDH1A1 | |
| SCHEMBL26260468 | 0.97 | HSD17B1 (0.38) | HSD17B1HSD17B2ALDH1A1SMN1; SMN2HSD17B10 | |
| SCHEMBL24372504 | 0.96 | ALDH1A1 (0.42) | HSD17B1HSD17B2PLA2G2APLA2G4AALDH1A1 | |
| SCHEMBL24655167 | 0.96 | ALDH1A1 (0.42) | HSD17B1HSD17B2PLA2G2APLA2G4AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230329097-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20230329097-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO LTD (KR) | 2023-10-12 | — | — | US | disclosed |
| US-20190214573-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190214573-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OR10J3, OCIAD2, OCIAD1 | HSD17B1 1348/4885HSD17B2 1213/4885PLA2G2A 1762/4885 |
| US-20230329097-A1 | COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OR10J3, OCIAD2, OCIAD1 | HSD17B1 1348/4885HSD17B2 1213/4885PLA2G2A 1762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.